Atomoxetine Use in Attention-Deficit/Hyperactivity Disorder and Comorbid Tic Disorder in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections

J Child Adolesc Psychopharmacol. 2017 Feb;27(1):104-105. doi: 10.1089/cap.2016.0065. Epub 2016 Jun 17.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a common comorbid disease in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS), in which tic-like involuntary movements are frequently seen clinical conditions. In contrast to psychostimulants, atomoxetine is considered as having minimal effects on tics. Here we report two cases with ADHD and PANDAS who were treated with atomoxetine for their ADHD and comorbid tics.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adrenergic Uptake Inhibitors / therapeutic use
  • Atomoxetine Hydrochloride / therapeutic use*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Autoimmune Diseases / drug therapy*
  • Child
  • Female
  • Humans
  • Male
  • Obsessive-Compulsive Disorder
  • Streptococcal Infections / drug therapy*
  • Tic Disorders / drug therapy*
  • Treatment Outcome

Substances

  • Adrenergic Uptake Inhibitors
  • Atomoxetine Hydrochloride

Supplementary concepts

  • Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections